near-significantP = 0.051
Regarding disease types, higher GAD-7–3 scores significantly increase the outcome risk in breast cancer patients (OR = 1.16, 95% CI 1.02–1.33); a strong near-significant trend is also observed in head and neck cancer patients (OR = 1.38, 95% CI 1.00–1.90, P = 0.051), but no association is found in abdominal cancer patients.